Vivos Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VVOS and other ETFs, options, and stocks.About VVOS
Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). Its solutions are also offered for patients with mild-to-moderate obstructive sleep apnea (OSA).
CEOR. Kirk Huntsman
CEOR. Kirk Huntsman
Employees109
Employees109
HeadquartersLittleton, Colorado
HeadquartersLittleton, Colorado
Founded2016
Founded2016
Employees109
Employees109
VVOS Key Statistics
Market cap19.50M
Market cap19.50M
Price-Earnings ratio-1.09
Price-Earnings ratio-1.09
Dividend yield—
Dividend yield—
Average volume141.66K
Average volume141.66K
High today$2.20
High today$2.20
Low today$2.05
Low today$2.05
Open price$2.10
Open price$2.10
Volume259.49K
Volume259.49K
52 Week high$7.95
52 Week high$7.95
52 Week low$1.98
52 Week low$1.98
Stock Snapshot
The current Vivos Therapeutics(VVOS) stock price is $2.10, with a market capitalization of 19.5M. The stock trades at a price-to-earnings (P/E) ratio of -1.09.
On 2025-12-09, Vivos Therapeutics(VVOS) stock moved within a range of $2.05 to $2.20. With shares now at $2.10, the stock is trading +2.5% above its intraday low and -4.5% below the session's peak.
Trading volume for Vivos Therapeutics(VVOS) stock has reached 259.49K, versus its average volume of 141.66K.
The stock's 52-week range extends from a low of $1.98 to a high of $7.95.
The stock's 52-week range extends from a low of $1.98 to a high of $7.95.
People also own
Based on the portfolios of people who own VVOS. This list is generated using Robinhood data, and it’s not a recommendation.